peptide tb 500 vs bpc 157 BPC-157 vs. TB-500: What Patients Should Know Functional Medicine The Colony TX

Antimicrobial activity: Early studies have also noted activity against pathogens including Staphylococcus aureus and Candida albicans, an area that continues to attract research interest

Compounded drugs are not FDA-approved and carry no manufacturer accountability or validated dosing protocol

Adding GHK-Cu introduces powerful matrix synthesis and gene modulation effects

Others, particularly BPC-157, have very limited human evidence

Despite their popularity, its crucial to approach these treatments with informed caution, considering the varying degrees of scientific support and the importance of professional medical guidance

159.21 g/mol (free cation portion) CAS: 90692-39-0 Disclaimer This product is intended for laboratory research use only